VHL and nonpapillary renal cell carcinoma: The VHL gene is mutated in 55-75% of ccRCC patient tumors [4, 40, 41], and an additional subset of ccRCC tumors harbor VHL promoter hypermethylation [42], resulting in VHL functional loss in approximately 90% of ccRCC tumors [43, 44].